|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Nephrology , Department of Cardiovascular Medicine, Graduate School of Medicine,, Kyoto University, Kyoto, Japan
2 Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan
3 Division of Nephrology, Kitano Hospital, Tazuke-Kofukai Foundation Medical Research Institute, Osaka, Japan
* To whom correspondence should be addressed. E-mail: ono{at}kuhp.kyoto-u.ac.jp.
It is well known that tissue factor starts the extrinsic coagulation pathway, which activates factor X to Xa, and factor V is a membrane-bound potent cofactor for the terminating stage of prothrombin activation by factor Xa. In a previous in vitro study, factor V was induced in cultured mesangial cells by inflammatory stimulation, and
increased expression of factor V promoted fibrin generation on the cultured mesangial cell surface. We report that extracellular matrix (ECM) accumulation is increased in association with coagulation in the mesangial area through factor V expression in mesangioproliferative glomerulonephritis (MsPGN). Wistar rats were intravenously injected with rabbit anti-rat thymocyte serum (ATS) accompanied with or without simultaneous injection of rabbit anti-factor V antibody. Time-course study
in immunohistochemistry revealed that factor V expression was prominent on day 3 and fibrin-related antigen (FRA) deposition, then ECM accumulation, followed from day 3 to day 8. Massive fibronectin depositions and TGF-
expression were also noted in glomeruli from the
disease control group, markedly higher than those in the normal group, and these depositions and expressions were significantly decreased in the antifactor V neutralizing antibody-injected group. Northern blot analysis revealed that factor V mRNA expression was prominent on day 3, and was weak on day 8. Double-labeling experiments revealed the frequent colocalization of
-smooth muscle actin (
-SMA) with factor V, FRA, and fibronectin, in the same mesangial areas of glomeruli. TGF-
, connective
tissue growth factor (CTGF), collagen type IV, and fibronectin mRNA were upregulated in the disease control group, and anti-factor V neutralizing antibody-injection suppressed these mRNA expressions in glomeruli. The
present results suggest that ECM components accumulation may progress in accordance with coagulation in the mesangial area through mesangial factor V expression and upregulated expression of TGF-
and CTGF in
MsPGN.
This article has been cited by other articles:
|
|
H. Saito, M. Kitamoto, K. Kato, N. Liu, H. Kitamura, K. Uemura, F. Nogaki, T. Takeda, N. Mori, and T. Ono TISSUE FACTOR AND FACTOR V INVOLVEMENT IN RAT PERITONEAL FIBROSIS Perit. Dial. Int., May 1, 2009; 29(3): 340 - 351. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |